ArticleNPJ breast cancer2023

Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data.

Nancy U Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.